Literature DB >> 19592172

Protective immune response in BALB/c mice induced by a suicidal DNA vaccine of the MIC3 gene of Toxoplasma gondii.

Rui Fang1, Hao Nie, Zhengsong Wang, Pan Tu, Danna Zhou, Lixia Wang, Lan He, Yanqin Zhou, Junlong Zhao.   

Abstract

To evaluate the protective efficiency of a suicidal DNA vaccine against protozoal parasite Toxoplasma gondii, the microneme protein 3 (MIC3) gene was cloned into suicidal vector pSCA1 and conventional DNA vaccine vector pcDNA3.1+ respectively, their protection against T. gondii challenge were assessed in this study. The recombinant plasmids named pSCA/MIC3 and pcDNA/MIC3 were transfected into BHK-21 cells. The expression of MIC3 in BHK-21 cells was confirmed by RT-PCR and indirect immunofluorescence test. Then BALB/c mice were immunized with pSCA/MIC3 or pcDNA/MIC3. Anti-Tg-MIC3 antibodies were detected by indirect ELISA and the cell immune response were examined by lymphocyte proliferation assay and real time RT-PCR. The results showed that the titre of anti-Tg-MIC3 antibodies, stimulation index (SI) of lymphocyte proliferation response and IFN-gamma expression level induced by pSCA/MIC3 and pcDNA/MIC3 were significantly higher than controls (P<0.05), whereas IL-4 expression level in BALB/c mice immunized with either pSCA/MIC3 or pcDNA/MIC3 was lower than that in control group. After a lethal challenge against T. gondii, survival time of the mice immunized with this suicidal DNA vaccine pSCA/MIC3 and conventional DNA vaccine pcDNA/MIC3 were significantly prolonged in comparison with the control groups (P<0.05), but the difference of protective immune response in BALB/c mice between pSCA/MIC3 and pcDNA/MIC3 was not statistically significant (P>0.05). The findings demonstrated that like conventional DNA vaccine pcDNA/MIC3, suicidal DNA vaccine pSCA/MIC3 also provided favourable efficacy, but it could improve the biosafety of conventional vaccines. This result suggested that suicidal DNA vaccine pSCA/MIC3 is a potential candidate vaccine against toxoplasmosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19592172     DOI: 10.1016/j.vetpar.2009.06.012

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  14 in total

1.  Recombinant expression of human nerve growth factor beta in rabbit bone marrow mesenchymal stem cells.

Authors:  Bo-Sheng Fan; Ji-Yu Lou
Journal:  Mol Biol Rep       Date:  2010-03-17       Impact factor: 2.316

2.  Protective immunity induced by a DNA vaccine-encoding Toxoplasma gondii microneme protein 11 against acute toxoplasmosis in BALB/c mice.

Authors:  Qing Tao; Rui Fang; Weichao Zhang; Yifan Wang; Jianxi Cheng; Yalin Li; Kun Fang; Muhammad Kasib Khan; Min Hu; Yanqin Zhou; Junlong Zhao
Journal:  Parasitol Res       Date:  2013-06-10       Impact factor: 2.289

Review 3.  REVIEW OF DNA VACCINE APPROACHES AGAINST THE PARASITE TOXOPLASMA GONDII.

Authors:  Rosalie C Warner; Ryan C Chapman; Brianna N Davis; Paul H Davis
Journal:  J Parasitol       Date:  2021-11-01       Impact factor: 1.276

4.  Evaluation of protective effect of multiantigenic DNA vaccine encoding MIC3 and ROP18 antigen segments of Toxoplasma gondii in mice.

Authors:  Daofeng Qu; Jianzhong Han; Aifang Du
Journal:  Parasitol Res       Date:  2013-04-17       Impact factor: 2.289

Review 5.  Research advances in microneme protein 3 of Toxoplasma gondii.

Authors:  Yanhua Wang; Hong Yin
Journal:  Parasit Vectors       Date:  2015-07-22       Impact factor: 3.876

6.  The quality of methods reporting in parasitology experiments.

Authors:  Oscar Flórez-Vargas; Michael Bramhall; Harry Noyes; Sheena Cruickshank; Robert Stevens; Andy Brass
Journal:  PLoS One       Date:  2014-07-30       Impact factor: 3.240

7.  Quantitation of cytokine mRNA by real-time RT-PCR during a vaccination trial in a rabbit model of fascioliasis.

Authors:  Ana M Espino; Francheska Rivera
Journal:  Vet Parasitol       Date:  2009-12-22       Impact factor: 2.738

8.  Vaccination with Recombinant Microneme Proteins Confers Protection against Experimental Toxoplasmosis in Mice.

Authors:  Camila Figueiredo Pinzan; Aline Sardinha-Silva; Fausto Almeida; Livia Lai; Carla Duque Lopes; Elaine Vicente Lourenço; Ademilson Panunto-Castelo; Stephen Matthews; Maria Cristina Roque-Barreira
Journal:  PLoS One       Date:  2015-11-17       Impact factor: 3.240

9.  Multicomponent DNA vaccine-encoding Toxoplasma gondii GRA1 and SAG1 primes: anti-Toxoplasma immune response in mice.

Authors:  Xiao-Nan Wu; Jie Lin; Xu Lin; Jie Chen; Zhong-Long Chen; Jian-Yin Lin
Journal:  Parasitol Res       Date:  2012-07-27       Impact factor: 2.289

10.  Toxoplasma gondii protein disulfide isomerase (TgPDI) is a novel vaccine candidate against toxoplasmosis.

Authors:  Hai-Long Wang; Ya-Qing Li; Li-Tian Yin; Xiao-Li Meng; Min Guo; Jian-Hong Zhang; Hong-Li Liu; Juan-Juan Liu; Guo-Rong Yin
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.